Anesthesia and analgesia
-
Anesthesia and analgesia · Apr 1999
Randomized Controlled Trial Comparative Study Clinical TrialThe influence of head and neck position on oropharyngeal leak pressure and cuff position with the flexible and the standard laryngeal mask airway.
We conducted a randomized, cross-over study of 20 paralyzed anesthetized adult patients to test the hypothesis that oropharyngeal leak pressure and cuff position (assessed fiberoptically) vary with head and neck position for the flexible (FLMA) and standard laryngeal mask airway (LMA). Both devices were inserted into each patient in random order. Oropharyngeal leak pressure and fiberoptic position (including degree of rotation) were documented in four head and neck positions (neutral first, then flexion, then extension and rotation in random order) for each device. The size 5 was used for all patients, and the intracuff pressure was set at 60 cm H2O in the neutral position. All airway devices were inserted at the first attempt. Oropharyngeal leak pressure was similar for the FLMA and LMA in the neutral (22 vs 21 cm H2O), flexed (26 vs 26 cm H2O), and extended positions (19 vs 18 cm H2O) but was slightly higher for the LMA when the head was rotated (19 vs 22 cm H2O; P = 0.04). Compared with the neutral position, oropharyngeal leak pressure for the LMA was higher with flexion (26 vs 21 cm H2O; P = 0.0004) and lower with extension (18 vs 21 cm H2O; P = 0.03) but similar with rotation. Compared with the neutral position, oropharyngeal leak pressure for the FLMA was higher with flexion (26 vs 22 cm H2O; P = 0.0001) and lower with extension (19 vs 22 cm H2O; P = 0.03) and rotation (19 vs 22 cm H2O; P = 0.03). The difference in oropharyngeal leak pressure between flexion and extension was 7 and 8 cm H2O for the FLMA and LMA, respectively. Fiberoptic position was similar between devices and was unchanged by head and neck position. Rotation was not detected fiberoptically. We conclude that there are small changes in oropharyngeal leak pressure but no changes in cuff position in different head and neck positions for the FLMA and LMA. Oropharyngeal leak pressure may be improved by head and neck flexion and by avoiding extension. ⋯ There are small changes in oropharyngeal leak pressure but no changes in cuff position in different head and neck positions for the flexible and standard laryngeal mask airways. Oropharyngeal leak pressure may be improved by head and neck flexion and by avoiding extension.
-
Anesthesia and analgesia · Apr 1999
Comparative Study Clinical Trial Controlled Clinical TrialTracheal extubation of deeply anesthetized pediatric patients: a comparison of isoflurane and sevoflurane.
We studied the emergence characteristics of unpremedicated children tracheally extubated while deeply anesthetized ("deep extubation") with isoflurane or sevoflurane. Forty children were assigned to one of two groups, Group I or Group S. At the end of the operation, Group I patients were extubated while breathing 1.5 times the minimum alveolar anesthetic concentration (MAC) of isoflurane. Group S patients were tracheally extubated while breathing 1.5 times the MAC of sevoflurane. Recovery characteristics and complications were noted. Group S patients were arousable sooner than Group I patients (10.1 + 6.5 vs 16.3 + 9.9 min). Later arousal scores and times to discharge were the same. There were no serious complications in either group. Breath-holding was more common in Group I. We conclude that the overall incidence of airway problems and desaturation episodes was similar between groups. Emergency delirium was common in both groups (32% overall: 40% for Group I, 25% for Group S). ⋯ Deep extubation of children can be safely performed with either isoflurane or sevoflurane. After deep tracheal extubation, airway problems occur but are easily managed. Return to an arousable state occurred more quickly with sevoflurane, although time to meeting discharge criteria was not different between the two groups. Emergence delirium occurs frequently with either technique.
-
Anesthesia and analgesia · Apr 1999
Randomized Controlled Trial Clinical TrialDo laryngeal mask airway devices attenuate liquid flow between the esophagus and pharynx? A randomized, controlled cadaver study.
In this randomized, controlled cadaver study, we tested the hypothesis that the standard laryngeal mask airway (LMA) and flexible laryngeal mask airway (FLMA) attenuate liquid flow between the esophagus and pharynx. Fifty fresh cadavers were studied in four LMA groups. Ten female cadavers had a size 4 LMA and 10 had a size 4 FLMA; 10 male cadavers had a size 5 LMA and 10 had a size 5 FLMA; 5 male and 5 female cadavers functioned as controls. The chest was opened, and the infusion set of a pressure-controlled, continuous flow pump was inserted into the esophagus and ligated into place. Esophageal pressure was increased in 2-cm H2O increments. Regurgitation pressure was the esophageal pressure at which fluid was first seen with a fiberoptic scope in the hypopharynx (control group) and above the cuff or within the bowl (LMA groups). This was performed in the LMA groups at 0-40 mL cuff volume in 10-mL increments. Mean (95% confidence interval) regurgitation pressure for the control group was 7 (6-8) cm H2O and for the LMA groups combined was 19 (17-20) cm H2O at 0 mL cuff volume, 47 (41-52) cm H2O at 10 mL, 51 (44-55) cm H2O at 20 mL, 52 (45-56) cm H2O at 30 mL, and 52 (45-55) cm H2O at 40 mL. The increase in regurgitation pressure with increasing cuff volume from 0 to 10 mL was statistically significant (P < 0.0001). Regurgitation pressure was higher for the LMA groups at all cuff volumes compared with the control group (P < 0.0001). There were no differences in regurgitation pressure among the LMA groups. We conclude that the correctly placed LMA and FLMA attenuate liquid flow between the esophagus and pharynx. ⋯ We have shown, in cadavers, that the correctly placed standard and flexible laryngeal mask airways attenuate liquid flow between the pharynx and esophagus.
-
Anesthesia and analgesia · Apr 1999
ReviewAlcohol withdrawal in the surgical patient: prevention and treatment.
In the literature on AWS, there is repeated emphasis on performing a thorough preanesthesia assessment in patients with suspected chronic alcohol use. Because these patients are difficult to diagnose and to treat in surgical settings if complications arise, a multimodal approach is highly recommended (86). Ideally, AWS should be prevented by adequate prophylaxis. ⋯ The drug regimens must be individualized and symptom-oriented to treat hallucinations and autonomic signs. Dosages are generally larger than those in detoxification units. Other approaches to modulate the neuroendocrine-immune axis in patients with an increased risk of postoperative infectious complications look promising but await controlled trials.
-
Anesthesia and analgesia · Apr 1999
Clinical TrialA dose-response study of intravenous regional anesthesia with meperidine.
Intravenous regional anesthesia (IVRA) with meperidine in doses > or = 100 mg provides effective postoperative analgesia. However, this technique is associated with excessive opioid-related side effects, which limit its clinical usefulness. The minimal dose of meperidine that is effective for IVRA has yet to be established. We added 0, 10, 20, 30, 40, or 50 mg of meperidine to 0.5% lidocaine IVRA for either carpal tunnel or tenolysis surgery. Pain and sedation scores and the incidence of side effects were assessed in the postanesthesia care unit. The duration of analgesia, defined as the time to first request for pain medications, and use of acetaminophen/codeine (T3) tablets were measured. The duration of analgesia increased, in a dose-dependent manner, in the groups that received 0, 10, 20, and 30 mg of meperidine. There was no significant difference in the duration of analgesia for patients receiving > or = 30 mg of meperidine. T3 use was similar in the groups that received 0, 10, and 20 mg of meperidine and in the groups that received 30, 40, and 50 mg. T3 use was significantly lower in the larger dose groups. The incidence of sedation and of all other side effects was significantly higher in the groups that received 30-50 mg of meperidine compared with those that received smaller doses. We conclude that doses of meperidine large enough to produce the most effective postoperative analgesia with IVRA lidocaine causes a significant incidence of side effects, thus limiting its clinical usefulness. ⋯ Meperidine may be a useful addition to 0.5% lidocaine for i.v. regional anesthesia. We showed that 30 mg is the optimal dose of meperidine with respect to postoperative analgesia. However, this dose caused a significant incidence of sedation, dizziness, and postoperative nausea and vomiting.